Four patents currently held, every record listed here
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2035. from the record
Of the 2 now held by other companies, 1 name Agilent Technologies Inc. as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jun 2035
Next term end
2
Patent families
When these terms end
Each bar runs from grant to computed term end. 2020 to 2042.
US 11,585,806
General Detection and Isolation of Specific Cells by Binding of Labeled Molecules
Jun 15, 2035
US 11,402,373
General Detection and Isolation of Specific Cells by Binding of Labeled Molecules
Jun 15, 2035
US 11,668,705
General Detection and Isolation of Specific Cells by Binding of Labeled Molecules
Jun 15, 2035
20252030203520402042
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
6 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Jun 2035 · High confidence
Also notable
Ends Jul 2042 · High confidence
General Detection and Isolation of Specific Cells by Binding of Labeled Molecules
US 11,585,806
The most cited patent in this portfolio, cited by 131 later US patents, top 1% of utility patents granted in 2023 in our data. Protection runs to 2035.
Panel comprising Borrelia MHC multimers
US 12,258,373
Granted 2025. Too new for citation comparison; protection runs to 2042.
Formerly held, still cited
Notable
Ends Feb 2033 · High confidence
The most cited patent in this portfolio, cited by 207 later US patents, top 1% of utility patents granted in 2020 in our data. Protection runs to 2033.
now held by Agilent Technologies, Inc.
Also notable
Ends no later than Oct 2042 · Medium confidence
A family of 5 related applications built on the 2026 grant. Too new for citation comparison; protection runs to 2042. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by Augusta Spinco Corporation
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 6, 2026The maintenance fee for General Detection and Isolation of Specific Cells by Binding of Labeled Molecules (US 11,668,705) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| General Detection and Isolation of Specific Cells by Binding of Labeled Molecules | 3 in force | to Jun 2035 |
| Panel comprising Borrelia MHC multimers | 1 in force | to Jul 2042 |
Patents held now
Soonest term end first.
Showing 1 to 4 of 4
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,402,373 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules In force · High confidence | In force | High confidence | |
| US 11,585,806 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules In force · High confidence | In force | High confidence | |
| US 11,668,705 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules In force · High confidence | In force | High confidence | |
| US 12,258,373 | Panel comprising Borrelia MHC multimers In force · High confidence | In force | High confidence |
Also on record, not counted in the 4: 2 patents in force now held by others · 6 applications pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed